1. Home
  2. GRFS vs MIR Comparison

GRFS vs MIR Comparison

Compare GRFS & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Grifols S.A.

GRFS

Grifols S.A.

HOLD

Current Price

$9.24

Market Cap

6.2B

Sector

Health Care

ML Signal

HOLD

Logo Mirion Technologies Inc.

MIR

Mirion Technologies Inc.

HOLD

Current Price

$25.69

Market Cap

5.7B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
GRFS
MIR
Founded
1940
2005
Country
Spain
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Machinery/Components
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.7B
IPO Year
2006
N/A

Fundamental Metrics

Financial Performance
Metric
GRFS
MIR
Price
$9.24
$25.69
Analyst Decision
Hold
Strong Buy
Analyst Count
2
8
Target Price
$10.15
$28.38
AVG Volume (30 Days)
465.4K
2.0M
Earning Date
07-28-2022
02-10-2026
Dividend Yield
1.56%
N/A
EPS Growth
N/A
N/A
EPS
0.64
0.10
Revenue
$8,821,017,248.00
$902,300,000.00
Revenue This Year
$5.36
$8.75
Revenue Next Year
$5.15
$23.17
P/E Ratio
$17.74
$262.95
Revenue Growth
7.31
7.82
52 Week Low
$6.19
$12.00
52 Week High
$11.14
$30.28

Technical Indicators

Market Signals
Indicator
GRFS
MIR
Relative Strength Index (RSI) 53.73 51.02
Support Level $8.63 $25.73
Resistance Level $9.40 $27.49
Average True Range (ATR) 0.23 1.09
MACD -0.02 0.11
Stochastic Oscillator 64.36 50.54

Price Performance

Historical Comparison
GRFS
MIR

About GRFS Grifols S.A.

Grifols SA one of is global specialty plasma therapeutics companies developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. Plasma derivatives are proteins found in human plasma, which once isolated and purified, have therapeutic value. These protein-based therapies extend and enhance the lives of individuals who suffer from chronic and acute, often life-threatening, conditions, including primary and secondary immunological deficiencies, Chronic Inflammatory Demyelinating Polyneuropathy, immune-mediated ITP. Products and services are used to diagnose and treat patients with hemophilia, immune deficiencies, infectious diseases and a range of other medical conditions. Majority of revenue is from USA.

About MIR Mirion Technologies Inc.

Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.

Share on Social Networks: